DuoTrav (travoprost;timolol)
- Region
- 🇪🇺 EU
- Active substance
- travoprost;timolol
- Company
- Novartis Europharm Limited
- Status
- Authorised
- Therapeutic area
- Glaucoma, Open-Angle; Ocular Hypertension
- CHMP opinion
- Thu 23 Feb 2006
- EU approval
- Sun 23 Apr 2006
- Application
- EMEA/H/C/000665
- ATC
- S01ED51
- Official record
- www.ema.europa.eu
Indication
Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Regulatory milestones
No milestones recorded in the last year.
Follow DuoTrav
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.